The PharmaTimes interview
A chat with Greg Flynn – Global President at Inizio Engage
Read More
Author: PharmaTimes
Dr Hamed Tabatabaei Ghomi made Head of Research at Optibrium
Optibrium, a leading developer of software and AI solutions for drug discovery, has announced the...
Read More
Dr Hamed Tabatabaei Ghomi made Head of Research at Optibrium
Optibrium, a leading developer of software and AI solutions for drug discovery, has announced the...
Read More
Stéphanie Colloud appointed General Manager at ABL
ABL, a company focused on viruses for gene therapy, oncolytic viruses and vaccine candidates, has...
Read More
Stéphanie Colloud appointed General Manager at ABL
ABL, a company focused on viruses for gene therapy, oncolytic viruses and vaccine candidates, has...
Read More- European life sciences coalition launched to boost investment ecosystem
- 99mtc‑maraciclatide granted fast track status for ILD imaging
- Bioxytran reports rapid viral clearance in phase 2 trial
- Thx Pharma and Biocodex sign rare disease licensing deal
- AstraZeneca bladder cancer therapy wins NICE backing
